Refractory epilepsy treatment utilizes an individual's distinct clinical, molecular, and lifestyle data to inform the diagnosis, treatment, and prevention of cancer, inherited diseases, and other ...

A team of researchers from the Universitat Politècnica de València (UPV) has participated in the development of Epileptika. This application aims to help the treatment of refractory epilepsy in people ...

January 14, 2009 — A US Food and Drug Administration (FDA) committee has voted unanimously that vigabatrin (Sabril, Ovation Pharmaceuticals) should be approved for use in the United States. Vigabatrin ...

Please provide your email address to receive an email when new articles are posted on . Focal cortex stimulation with an implantable device reduced seizure activity in more than 50% of participants at ...

Investment from XGEN Venture, British Business Bank, and a global biopharmaceutical company will support first-in-human Phase 1/2a clinical trials for lead candidate EPY201 targeting focal refractory ...

A rare condition that presents with refractory and many times super-refractory status epilepticus, NORSE, including its subtype febrile infection related epilepsy syndrome (FIRES), is heterogeneous ...

A research team proposes an innovative sequential narrow-field deep brain stimulation procedure to treat intractable epilepsy. Epilepsy is a chronic brain disorder characterized by recurrent seizures.

Abstracts from the American Epilepsy Society (AES) display potential benefits of cannabidiol (CBD) on pediatric patients with epilepsy in tertiary care centers and highlight areas where further ...

LONDON--(BUSINESS WIRE)--EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat focal refractory epilepsy, today announced it has raised a ...